Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
Lynnae M. Smith, Mya C. Schiess, Mary P. Coffey, et al.
PLoS ONE (2012) Vol. 7, Iss. 12, pp. e52285-e52285
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Alpha‐Synuclein as a Biomarker for Parkinson's Disease
Anzari Atik, Tessandra Stewart, Jing Zhang
Brain Pathology (2016) Vol. 26, Iss. 3, pp. 410-418
Open Access | Times Cited: 257
Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review
Naveed Malek, Diane M.A. Swallow, Katherine A. Grosset, et al.
Acta Neurologica Scandinavica (2014) Vol. 130, Iss. 2, pp. 59-72
Open Access | Times Cited: 154
Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson's disease
Talita Tuon, Samira S. Valvassori, G.C. Dal Pont, et al.
Brain Research Bulletin (2014) Vol. 108, pp. 106-112
Closed Access | Times Cited: 103
Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease
Nataša Kuštrimović, Emanuela Rasini, Massimiliano Legnaro, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 102
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Chen Tian, Genliang Liu, Liyan Gao, et al.
Translational Neurodegeneration (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 92
Parkinson's disease in women: Mechanisms underlying sex differences
Bhupesh Vaidya, Kritika Dhamija, Priyanka Guru, et al.
European Journal of Pharmacology (2021) Vol. 895, pp. 173862-173862
Closed Access | Times Cited: 61
Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases
Michael Poppell, Grace Hammel, Yi Ren
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5925-5925
Open Access | Times Cited: 21
Immunological shifts during early-stage Parkinson’s disease identified with DNA methylation data on longitudinally collected blood samples
Steven C. Pike, Matthew C. Havrda, Francesca Gilli, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Immunochemical Detection of α-Synuclein Autoantibodies in Parkinson’s Disease: Correlation between Plasma and Cerebrospinal Fluid Levels
István Horváth, Igor A. Iashchishyn, Lars Forsgren, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 6, pp. 1170-1176
Closed Access | Times Cited: 59
Neurochemical correlation between major depressive disorder and neurodegenerative diseases
Gislaine Z. Réus, Stephanie E. Titus, Helena M. Abelaira, et al.
Life Sciences (2016) Vol. 158, pp. 121-129
Closed Access | Times Cited: 54
Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson’s Disease after Elimination of Heterophilic Antibody Interference
Ryotaro Ishii, Takahiko Tokuda, Harutsugu Tatebe, et al.
PLoS ONE (2015) Vol. 10, Iss. 4, pp. e0123162-e0123162
Open Access | Times Cited: 53
Immunotherapy Targeting α-Synuclein, with Relevance for Future Treatment of Parkinson‘s Disease and Other Lewy Body Disorders
Veronica Lindström, Elisabet Ihse, Therese Fagerqvist, et al.
Immunotherapy (2014) Vol. 6, Iss. 2, pp. 141-153
Closed Access | Times Cited: 52
Autoimmune antibody decline in Parkinson’s disease and Multiple System Atrophy; a step towards immunotherapeutic strategies
Tomasz Brudek, Kristian Winge, Jonas Folke, et al.
Molecular Neurodegeneration (2017) Vol. 12, Iss. 1
Open Access | Times Cited: 51
A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease
Kirsten M. Scott, Antonina Kouli, Su L. Yeoh, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 49
Voluntary Physical Exercise Improves Subsequent Motor and Cognitive Impairments in a Rat Model of Parkinson’s Disease
Shih‐Chang Hsueh, Kai‐Yun Chen, Jing-Huei Lai, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 508-508
Open Access | Times Cited: 48
Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease
Mya C. Schiess, Jessika Suescun, Marie‐Françoise Doursout, et al.
Movement Disorders (2021) Vol. 36, Iss. 8, pp. 1825-1834
Open Access | Times Cited: 38
Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions
Félix Javier Jiménez‐Jiménez, Hortensia Alonso‐Navarro, Elena García‐Martín, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1263-1263
Open Access | Times Cited: 14
Disruption of oxidative balance in the gut of the western honeybee Apis mellifera exposed to the intracellular parasite Nosema ceranae and to the insecticide fipronil
Laurianne Paris, Michaël Roussel, Bruno Pereira, et al.
Microbial Biotechnology (2017) Vol. 10, Iss. 6, pp. 1702-1717
Open Access | Times Cited: 47
Alpha-Synuclein Levels in Blood Plasma Decline with Healthy Aging
Niklas Koehler, Elke Stransky, Mirjam Meyer, et al.
PLoS ONE (2015) Vol. 10, Iss. 4, pp. e0123444-e0123444
Open Access | Times Cited: 45
Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology
Xinyi Li, Wouter Koudstaal, Lauren Fletcher, et al.
Acta Neuropathologica (2019) Vol. 137, Iss. 5, pp. 825-836
Open Access | Times Cited: 40
Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases
Gabriela Kocurova, Jan Říčný, Saak V. Ovsepian
Theranostics (2022) Vol. 12, Iss. 7, pp. 3045-3056
Open Access | Times Cited: 20
Utility of Autoantibodies as Biomarkers for Diagnosis and Staging of Neurodegenerative Diseases
Cassandra DeMarshall, Abhirup Sarkar, Eric P. Nagele, et al.
International review of neurobiology (2015), pp. 1-51
Closed Access | Times Cited: 40
Update on the role of p75NTR in neurological disorders: A novel therapeutic target
Ya-Hai Shu, Xiu‐Min Lu, Jing-Xiang Wei, et al.
Biomedicine & Pharmacotherapy (2015) Vol. 76, pp. 17-23
Closed Access | Times Cited: 39
The relation between plasma α-synuclein level and clinical symptoms or signs of Parkinson's disease
Michalina Malec‐Litwinowicz, Andrzej Plewka, Danuta Plewka, et al.
Neurologia i Neurochirurgia Polska (2017) Vol. 52, Iss. 2, pp. 243-251
Closed Access | Times Cited: 38
Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson’s Disease
Jonas Folke, Rasmus Rydbirk, Annemette Løkkegaard, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top